Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 for tumor-biological risk assessment in node-negative breast cancer patients – The multicenter trial NNBC 3-Europe

✍ Scribed by C. Thomssen; M. Vetter; D. Paepke; M. Schmidt; C. Veyret; D. Augustin; V. Hanf; P. Martin; G. von Minckwitz; N. Harbeck

• Book ID: 119598275
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 75 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)70783-3